ReviewCancers2022
Moving Immune Checkpoint Inhibitors to Early Non-Small Cell Lung Cancer: A Narrative Review.
Giuseppe Viscardi et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
2 papers cite it
this papercites it
ReviewCancers2022
Giuseppe Viscardi et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.